Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 185

1.

Non-cirrhotic hyperammonemia after deceased donor kidney transplantation: A case report.

Li GZ, Tio MC, Pak LM, Krier J, Tullius SG, Riella LV, Malek SK, Stergachis AB.

Am J Transplant. 2019 Jul 25. doi: 10.1111/ajt.15545. [Epub ahead of print]

PMID:
31347272
2.

Estimating the costs of HIV clinic integrated versus non-integrated treatment of pre-cancerous cervical lesions and costs of cervical cancer treatment in Kenya.

Vodicka EL, Chung MH, Zimmermann MR, Kosgei RJ, Lee F, Mugo NR, Okech TC, Sakr SR, Stergachis A, Garrison LP Jr, Babigumira JB.

PLoS One. 2019 Jun 6;14(6):e0217331. doi: 10.1371/journal.pone.0217331. eCollection 2019.

3.

Maternal interventions vigilance harmonization in low- and middle-income countries: Stakeholder meeting report; Amsterdam, May 1-2, 2018.

Sobanjo-Ter Meulen A, Munoz FM, Kaslow DC, Klugman KP, Omer SB, Vora P, Stergachis A.

Vaccine. 2019 May 6;37(20):2643-2650. doi: 10.1016/j.vaccine.2019.03.060. Epub 2019 Apr 4.

4.

Recurrent SLC1A2 variants cause epilepsy via a dominant negative mechanism.

Stergachis AB, Pujol-Giménez J, Gyimesi G, Fuster D, Albano G, Troxler M, Picker J, Rosenberg PA, Bergin A, Peters J, El Achkar CM, Harini C, Manzi S, Rotenberg A, Hediger MA, Rodan LH.

Ann Neurol. 2019 Jun;85(6):921-926. doi: 10.1002/ana.25477. Epub 2019 Apr 26.

PMID:
30937933
5.

Strengthening the evidence-base on payment models for pharmacist-provided services.

Stergachis A.

J Am Pharm Assoc (2003). 2019 Jan - Feb;59(1):5. doi: 10.1016/j.japh.2018.12.016. No abstract available.

PMID:
30660320
6.

The effects of vaccination forecasts and value-based payment on adult immunizations by community pharmacists.

Bacci JL, Hansen R, Ree C, Reynolds MJ, Stergachis A, Odegard PS.

Vaccine. 2019 Jan 3;37(1):152-159. doi: 10.1016/j.vaccine.2018.11.018. Epub 2018 Nov 13.

PMID:
30446177
7.

Translating medicines to patients: A novel methodology for quantifying the global medical supplies and donations program.

Li SJ, Vodicka E, Peterson A, Stergachis A.

PLoS One. 2018 Nov 2;13(11):e0206790. doi: 10.1371/journal.pone.0206790. eCollection 2018.

8.

Expanding global access to essential medicines: investment priorities for sustainably strengthening medical product regulatory systems.

Roth L, Bempong D, Babigumira JB, Banoo S, Cooke E, Jeffreys D, Kasonde L, Leufkens HGM, Lim JCW, Lumpkin M, Mahlangu G, Peeling RW, Rees H, Ndomondo-Sigonda M, Stergachis A, Ward M, Nwokike J.

Global Health. 2018 Nov 1;14(1):102. doi: 10.1186/s12992-018-0421-2. Review.

9.

Integrative Genomics Analysis Identifies ACVR1B as a Candidate Causal Gene of Emphysema Distribution.

Boueiz A, Pham B, Chase R, Lamb A, Lee S, Naing ZZC, Cho MH, Parker MM, Sakornsakolpat P, Hersh CP, Crapo JD, Stergachis AB, Tal-Singer R, DeMeo DL, Silverman EK, Zhou X, Castaldi PJ; COPDGene investigators, by Core Units:, ECLIPSE Investigators:, GenKOLS Investigators:.

Am J Respir Cell Mol Biol. 2019 Apr;60(4):388-398. doi: 10.1165/rcmb.2018-0110OC.

PMID:
30335480
10.

The quality of anti-malarial medicines in Embu County, Kenya.

Ndwigah S, Stergachis A, Abuga K, Mugo H, Kibwage I.

Malar J. 2018 Sep 15;17(1):330. doi: 10.1186/s12936-018-2482-3.

11.

Enhancements to JAPhA.

Stergachis A.

J Am Pharm Assoc (2003). 2018 Sep - Oct;58(5):469. doi: 10.1016/j.japh.2018.08.004. No abstract available.

PMID:
30190107
12.

When government agencies turn to unregulated drug sources: Implications for the drug supply chain and public health are grave.

Yadav P, Weintraub RL, Stergachis A.

J Am Pharm Assoc (2003). 2018 Sep - Oct;58(5):477-480. doi: 10.1016/j.japh.2018.06.019. Epub 2018 Aug 1.

PMID:
30077566
13.

A pharmacovigilance system for treatment access and medical donation programs: The Max Foundation experience.

Novakowski AK, Garcia-Gonzalez P, Wrigglesworth M, Stergachis A.

Global Health. 2018 Jul 27;14(1):76. doi: 10.1186/s12992-018-0391-4.

14.

Measuring and mapping the global burden of antimicrobial resistance.

Hay SI, Rao PC, Dolecek C, Day NPJ, Stergachis A, Lopez AD, Murray CJL.

BMC Med. 2018 Jun 4;16(1):78. doi: 10.1186/s12916-018-1073-z.

15.

Assessment tool for establishing local pharmaceutical manufacturing in low- and middle-income countries.

Zimmermann M, Adamson B, Lam-Hine T, Rennie T, Stergachis A.

Int J Pharm Pract. 2018 Aug;26(4):364-368. doi: 10.1111/ijpp.12455. Epub 2018 May 6.

PMID:
29732641
16.

Expanding the clinical spectrum of biallelic ZNF335 variants.

Stouffs K, Stergachis AB, Vanderhasselt T, Dica A, Janssens S, Vandervore L, Gheldof A, Bodamer O, Keymolen K, Seneca S, Liebaers I, Jayaraman D, Hill HE, Partlow JN, Walsh CA, Jansen AC.

Clin Genet. 2018 Aug;94(2):246-251. doi: 10.1111/cge.13260. Epub 2018 May 3.

17.

A qualitative assessment of the challenges of WHO prequalification for anti-malarial drugs in China.

Huang Y, Pan K, Peng D, Stergachis A.

Malar J. 2018 Apr 3;17(1):149. doi: 10.1186/s12936-018-2303-8.

18.

From mass gatherings medicine to mass gatherings health: Conclusions from the 3rd International Conference on Mass Gatherings Medicine, Riyadh, Kingdom of Saudi Arabia.

Yezli S; WHO Collaborating Centre on Mass Gatherings Medicine, Assiri A, Nabulsi H, Awam A; WHO Collaborating Centre on Mass Gatherings Medicine, Blumberg L, Endericks T; WHO Collaborating Centre for Mass Gatherings and Global Health Security, Stergachis A; WHO Collaborating Centre on Mass Gatherings Public Health, Reicher S, McCloskey B; WHO Collaborating Centre for Mass Gatherings and Global Health Security, Petersen E, Alotaibi B; WHO Collaborating Centre on Mass Gatherings Medicine.

Int J Infect Dis. 2018 Jan;66:128-130. doi: 10.1016/j.ijid.2017.12.019. No abstract available.

19.

A Comparison of Adverse Drug Reaction Profiles in Patients on Antiretroviral and Antitubercular Treatment in Zimbabwe.

Masuka JT, Chipangura P, Nyambayo PP, Stergachis A, Khoza S.

Clin Drug Investig. 2018 Jan;38(1):9-17. doi: 10.1007/s40261-017-0579-z.

PMID:
28965312
20.

Impact of pharmacy worker training and deployment on access to essential medicines for children under five in Malawi: a cluster quasi-experimental evaluation.

Babigumira JB, Lubinga SJ, Jenny AM, Larsen-Cooper E, Crawford J, Matemba C, Stergachis A.

BMC Health Serv Res. 2017 Sep 11;17(1):638. doi: 10.1186/s12913-017-2530-7.

21.

Announcing Advances in Pharmacy Practice.

Stergachis A.

J Am Pharm Assoc (2003). 2017 Jul - Aug;57(4):425. doi: 10.1016/j.japh.2017.06.016. No abstract available.

PMID:
28712456
22.

Donor support for quality assurance and pharmacovigilance of anti-malarials in malaria-endemic countries.

Kovacs SD, Mills BM, Stergachis A.

Malar J. 2017 Jul 11;16(1):282. doi: 10.1186/s12936-017-1921-x.

23.

A single nucleotide polymorphism of cyclin-dependent kinase inhibitor 1B (p27Kip1) associated with human vein graft failure affects growth of human venous adventitial cells but not smooth muscle cells.

Kenagy RD, Kikuchi S, Chen L, Wijelath ES, Stergachis AB, Stamatoyannopoulos J, Tang GL, Clowes AW, Sobel M.

J Vasc Surg. 2018 Jan;67(1):309-317.e7. doi: 10.1016/j.jvs.2016.12.113. Epub 2017 May 16.

24.

Capacity for diagnosis and treatment of heart failure in sub-Saharan Africa.

Carlson S, Duber HC, Achan J, Ikilezi G, Mokdad AH, Stergachis A, Wollum A, Bukhman G, Roth GA.

Heart. 2017 Dec;103(23):1874-1879. doi: 10.1136/heartjnl-2016-310913. Epub 2017 May 10.

PMID:
28490619
25.

First-trimester artemisinin derivatives and quinine treatments and the risk of adverse pregnancy outcomes in Africa and Asia: A meta-analysis of observational studies.

Dellicour S, Sevene E, McGready R, Tinto H, Mosha D, Manyando C, Rulisa S, Desai M, Ouma P, Oneko M, Vala A, Rupérez M, Macete E, Menéndez C, Nakanabo-Diallo S, Kazienga A, Valéa I, Calip G, Augusto O, Genton B, Njunju EM, Moore KA, d'Alessandro U, Nosten F, Ter Kuile F, Stergachis A.

PLoS Med. 2017 May 2;14(5):e1002290. doi: 10.1371/journal.pmed.1002290. eCollection 2017 May.

26.

Safety, tolerability, and efficacy of repeated doses of dihydroartemisinin-piperaquine for prevention and treatment of malaria: a systematic review and meta-analysis.

Gutman J, Kovacs S, Dorsey G, Stergachis A, Ter Kuile FO.

Lancet Infect Dis. 2017 Feb;17(2):184-193. doi: 10.1016/S1473-3099(16)30378-4. Epub 2016 Nov 17. Review.

27.

The Safety of Artemisinin Derivatives for the Treatment of Malaria in the 2nd or 3rd Trimester of Pregnancy: A Systematic Review and Meta-Analysis.

Kovacs SD, van Eijk AM, Sevene E, Dellicour S, Weiss NS, Emerson S, Steketee R, Ter Kuile FO, Stergachis A.

PLoS One. 2016 Nov 8;11(11):e0164963. doi: 10.1371/journal.pone.0164963. eCollection 2016.

28.

Assessment of the scope and practice of evaluation among medical donation programs.

Jenny AM, Li M, Ashbourne E, Aldrink M, Funk C, Stergachis A.

Global Health. 2016 Nov 4;12(1):69.

29.

Improving safety, quality and efficacy of medicines in the Americas.

Bolaños R, Bond K, Child R, Coto JV, Cummings R, Dellepiane N, Fitzgerald J, Parker C, Pereira P, Sánchez Y Tépoz J, Stergachis A.

Rev Panam Salud Publica. 2016 May;39(5):215-216. No abstract available.

PMID:
27706408
30.

Pre-exposure Prophylaxis Use by Breastfeeding HIV-Uninfected Women: A Prospective Short-Term Study of Antiretroviral Excretion in Breast Milk and Infant Absorption.

Mugwanya KK, Hendrix CW, Mugo NR, Marzinke M, Katabira ET, Ngure K, Semiyaga NB, John-Stewart G, Muwonge TR, Muthuri G, Stergachis A, Celum CL, Baeten JM.

PLoS Med. 2016 Sep 27;13(9):e1002132. doi: 10.1371/journal.pmed.1002132. eCollection 2016 Sep.

31.

Development of a pharmacovigilance safety monitoring tool for the rollout of single low-dose primaquine and artemether-lumefantrine to treat Plasmodium falciparum infections in Swaziland: a pilot study.

Poirot E, Soble A, Ntshalintshali N, Mwandemele A, Mkhonta N, Malambe C, Vilakati S, Pan S, Darteh S, Maphalala G, Brown J, Hwang J, Pace C, Stergachis A, Vittinghoff E, Kunene S, Gosling R.

Malar J. 2016 Jul 22;15(1):384. doi: 10.1186/s12936-016-1410-7.

32.

Active Surveillance versus Spontaneous Reporting for First-Line Antiretroviral Medicines in Namibia: A Cost-Utility Analysis.

Mann M, Mengistu A, Gaeseb J, Sagwa E, Mazibuko G, Babigumira JB, Garrison LP Jr, Stergachis A.

Drug Saf. 2016 Sep;39(9):859-72. doi: 10.1007/s40264-016-0432-y.

PMID:
27314405
33.

Sentinel site active surveillance of safety of first-line antiretroviral medicines in Namibia.

Mann M, Mengistu A, Gaeseb J, Sagwa E, Mazibuko G, Baeten JM, Babigumira JB, Garrison LP, Stergachis A.

Pharmacoepidemiol Drug Saf. 2016 Sep;25(9):1052-60. doi: 10.1002/pds.4022. Epub 2016 May 2.

PMID:
27134056
34.

Weekly miscarriage rates in a community-based prospective cohort study in rural western Kenya.

Dellicour S, Aol G, Ouma P, Yan N, Bigogo G, Hamel MJ, Burton DC, Oneko M, Breiman RF, Slutsker L, Feikin D, Kariuki S, Odhiambo F, Calip G, Stergachis A, Laserson KF, ter Kuile FO, Desai M.

BMJ Open. 2016 Apr 15;6(4):e011088. doi: 10.1136/bmjopen-2016-011088.

35.

Selecting Optimal Peptides for Targeted Proteomic Experiments in Human Plasma Using In Vitro Synthesized Proteins as Analytical Standards.

Bollinger JG, Stergachis AB, Johnson RS, Egertson JD, MacCoss MJ.

Methods Mol Biol. 2016;1410:207-21. doi: 10.1007/978-1-4939-3524-6_12.

36.

Outpatient Mental Health Services in Mozambique: Use and Treatments.

Wagenaar BH, Cumbe V, Raunig-Berhó M, Rao D, Kohrt BA, Stergachis A, Napúa M, Sherr K.

Psychiatr Serv. 2016 Jun 1;67(6):588-90. doi: 10.1176/appi.ps.201500508. Epub 2016 Feb 1.

37.

JAPhA and Elsevier: A new beginning.

Stergachis A.

J Am Pharm Assoc (2003). 2016 Jan;56(1):11. doi: 10.1016/j.japh.2015.12.005. No abstract available.

PMID:
26802914
38.

Surgery for Family Planning, Abortion, and Postabortion Care.

Babigumira JB, Vlassoff M, Ahimbisibwe A, Stergachis A.

In: Debas HT, Donkor P, Gawande A, Jamison DT, Kruk ME, Mock CN, editors. Essential Surgery: Disease Control Priorities, Third Edition (Volume 1). Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2015 Apr 2. Chapter 7.

39.

A Randomized Controlled Trial of the Effectiveness of Traditional and Mobile Public Health Communications With Health Care Providers.

Baseman J, Revere D, Painter I, Oberle M, Duchin J, Thiede H, Nett R, MacEachern D, Stergachis A.

Disaster Med Public Health Prep. 2016 Feb;10(1):98-107. doi: 10.1017/dmp.2015.139. Epub 2015 Dec 22.

PMID:
26690370
40.

Assessment of the safety of antimalarial drug use during early pregnancy (ASAP): protocol for a multicenter prospective cohort study in Burkina Faso, Kenya and Mozambique.

Tinto H, Sevene E, Dellicour S, Calip GS, d'Alessandro U, Macete E, Nakanabo-Diallo S, Kazienga A, Valea I, Sorgho H, Valá A, Augusto O, Ruperez M, Menendez C, Ouma P, Desai M, Ter Kuile F, Stergachis A.

Reprod Health. 2015 Dec 4;12:112. doi: 10.1186/s12978-015-0101-0.

41.

Risks of miscarriage and inadvertent exposure to artemisinin derivatives in the first trimester of pregnancy: a prospective cohort study in western Kenya.

Dellicour S, Desai M, Aol G, Oneko M, Ouma P, Bigogo G, Burton DC, Breiman RF, Hamel MJ, Slutsker L, Feikin D, Kariuki S, Odhiambo F, Pandit J, Laserson KF, Calip G, Stergachis A, ter Kuile FO.

Malar J. 2015 Nov 18;14:461. doi: 10.1186/s12936-015-0950-6.

42.

Medication use for chronic health conditions among adults in Saudi Arabia: findings from a national household survey.

Moradi-Lakeh M, El Bcheraoui C, Daoud F, Tuffaha M, Wilson S, Al Saeedi M, Basulaiman M, Memish ZA, AlMazroa MA, Al Rabeeah AA, Stergachis A, Mokdad AH.

Pharmacoepidemiol Drug Saf. 2016 Jan;25(1):73-81. doi: 10.1002/pds.3904. Epub 2015 Oct 22.

PMID:
26494489
43.

Using Data Independent Acquisition (DIA) to Model High-responding Peptides for Targeted Proteomics Experiments.

Searle BC, Egertson JD, Bollinger JG, Stergachis AB, MacCoss MJ.

Mol Cell Proteomics. 2015 Sep;14(9):2331-40. doi: 10.1074/mcp.M115.051300. Epub 2015 Jun 22.

44.

The availability of essential medicines for mental healthcare in Sofala, Mozambique.

Wagenaar BH, Stergachis A, Rao D, Hoek R, Cumbe V, Napúa M, Sherr K.

Glob Health Action. 2015 Jun 15;8:27942. doi: 10.3402/gha.v8.27942. eCollection 2015.

45.

Influence of hospital and patient location on early postoperative outcomes after appendectomy and pyloromyotomy.

McAteer JP, Richards MK, Stergachis A, Abdullah F, Rangel SJ, Oldham KT, Goldin AB.

J Pediatr Surg. 2015 Sep;50(9):1549-55. doi: 10.1016/j.jpedsurg.2015.03.063. Epub 2015 Apr 25.

PMID:
25962842
46.

Actions of the National Regulatory Authorities in 10 Low- and Middle-Income Countries Following Stringent Regulatory Authority Safety Alerts on Rosiglitazone.

Nwokike J, Kabore L, Stergachis A.

Ther Innov Regul Sci. 2015 Mar;49(2):279-283. doi: 10.1177/2168479014551644.

PMID:
30222412
47.

Treating severe malaria in pregnancy: a review of the evidence.

Kovacs SD, Rijken MJ, Stergachis A.

Drug Saf. 2015 Feb;38(2):165-81. doi: 10.1007/s40264-014-0261-9. Review.

48.

Conservation of trans-acting circuitry during mammalian regulatory evolution.

Stergachis AB, Neph S, Sandstrom R, Haugen E, Reynolds AP, Zhang M, Byron R, Canfield T, Stelhing-Sun S, Lee K, Thurman RE, Vong S, Bates D, Neri F, Diegel M, Giste E, Dunn D, Vierstra J, Hansen RS, Johnson AK, Sabo PJ, Wilken MS, Reh TA, Treuting PM, Kaul R, Groudine M, Bender MA, Borenstein E, Stamatoyannopoulos JA.

Nature. 2014 Nov 20;515(7527):365-70. doi: 10.1038/nature13972.

49.

Metabolic syndrome and outcomes following early-stage breast cancer.

Calip GS, Malone KE, Gralow JR, Stergachis A, Hubbard RA, Boudreau DM.

Breast Cancer Res Treat. 2014 Nov;148(2):363-77. doi: 10.1007/s10549-014-3157-6. Epub 2014 Oct 10.

50.

Impact of pharmacy worker training and deployment on access to essential medicines and health outcomes in Malawi: protocol for a cluster quasi-experimental evaluation.

Lubinga SJ, Jenny AM, Larsen-Cooper E, Crawford J, Matemba C, Stergachis A, Babigumira JB.

Implement Sci. 2014 Oct 11;9:156. doi: 10.1186/s13012-014-0156-2.

Supplemental Content

Loading ...
Support Center